Joseph S. Zakrzewski - Jan 18, 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph Zakrzewski
Stock symbol
ANTX
Transactions as of
Jan 18, 2024
Transactions value $
-$1,911,410
Form type
4
Date filed
1/19/2024, 07:32 PM
Previous filing
Jun 9, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$1.91M -100K -19.77% $19.11 406K Jan 18, 2024 See footnote F1
holding ANTX Common Stock 98.2K Jan 18, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Z3 Trust, for which the Reporting Person is a trustee.

Remarks:

Exhibits: Power of Attorney